Comprehensive Care for Inherited Blood Disorders

Thalassemia Treatment in Bangalore

Thalassemia is an inherited blood disorder in which the body does not produce enough healthy haemoglobin. Specialist hematology care helps manage anaemia, transfusions, iron levels and long-term health.

What Is Thalassemia?

An inherited blood disorder affecting haemoglobin production, ranging from a mild trait to severe forms needing regular care.

Types
& Severity

Alpha and beta thalassemia, classified as trait, minor, intermedia or major depending on severity.

Diagnosis
& Testing

CBC, haemoglobin electrophoresis, iron studies and genetic testing confirm the type and severity.

Book a Consultation

Speak with Dr. Neema Bhat about diagnosis, treatment or a second opinion.

Dr Neema-Bhat

Thalassemia Specialist

Dr. Neema Bhat

MD (Cooper University Hospital, USA) · FAAP Fellowship, Pediatric Hematology, Oncology & BMT, Penn State Health · Gold Medalist, Physiology

What Is Thalassemia?

An inherited blood disorder affecting haemoglobin

Thalassemia is an inherited blood disorder in which the body does not produce enough healthy haemoglobin. Haemoglobin is the protein inside red blood cells that carries oxygen throughout the body. When the body produces insufficient or abnormal haemoglobin, red blood cells may not function normally, leading to anaemia and, in more severe forms, complications affecting different organs.

Thalassemia is a genetic condition passed from parents to children. It can affect the alpha or beta part of haemoglobin and can range from a mild carrier or trait state to more severe forms that require regular medical care.

Thalassemia Treatment in Bangalore depends on the specific type and severity of thalassemia, the patient’s age, haemoglobin levels, transfusion requirements, iron levels, organ health and other individual factors. Some people with thalassemia trait may require little or no treatment, while people with severe thalassemia may need regular blood transfusions, iron chelation therapy and long-term monitoring. Selected patients may also be evaluated for a blood or bone marrow transplant, which can potentially cure thalassemia.

What Causes It?

Inherited changes in the genes responsible for producing haemoglobin's alpha and beta globin chains. Terms like trait, minor, intermedia and major describe clinical severity.

Why Specialist Care Matters

Thalassemia is a lifelong condition that may need coordinated management of anaemia, transfusions, iron overload, nutrition, organ health and, in selected cases, stem cell transplantation.

── TYPES OF THALASSEMIA

Alpha and beta thalassemia

Alpha Thalassemia

Alpha thalassemia occurs when the body does not produce enough alpha-globin chains. Its severity depends on how many alpha-globin genes are affected — some people may have no significant symptoms, while more severe forms can cause substantial anaemia.

Beta Thalassemia

Beta thalassemia occurs when the production of beta-globin chains is reduced or absent. Depending on the inherited genetic changes and clinical severity, it may be described as trait/minor, intermedia, or major — a severe form that commonly requires regular blood transfusions.

Recognising the Signs

Symptoms of Thalassemia

Symptoms depend on the type and severity of the condition. Mild forms may cause no obvious symptoms, while moderate and severe forms can produce symptoms of anaemia — often identified during childhood.

  • Tiredness
  • Weakness
  • Pale skin
  • Shortness of breath
  • Dizziness
  • Headaches
  • Fast heartbeat
  • Poor exercise tolerance
  • Poor appetite
  • Slow growth in children
  • Abdominal swelling due to an enlarged spleen or liver
  • Jaundice in some patients
  • Bone changes in severe, untreated disease

Moderate and severe thalassemias are often identified during childhood because symptoms of significant anaemia can appear early.

Not every person with fatigue or low haemoglobin has thalassemia. Similar symptoms can occur with iron deficiency, nutritional anaemia and other conditions, which is why appropriate testing is important.

How Is Thalassemia Diagnosed?

Diagnosis & Testing

Diagnosis involves assessing blood counts, haemoglobin patterns and, when appropriate, genetic information.

The evaluation may include:

  • Complete blood count (CBC)
  • Haemoglobin measurement
  • Red blood cell indices
  • Peripheral blood smear
  • Special haemoglobin testing
  • Haemoglobin electrophoresis or related haemoglobin analysis
  • Iron studies when required
  • Genetic testing
  • Family history assessment

A CBC can identify low haemoglobin and changes in red blood cell characteristics. Special haemoglobin tests can help distinguish different haemoglobin disorders, while genetic testing can help identify the specific type of thalassemia in appropriate cases.

Treatment Options

Thalassemia Treatment Options

The appropriate Thalassemia Treatment in Bangalore depends on the type and severity of the condition.

Blood Transfusion for Thalassemia

Blood transfusions are a major part of treatment for many people with moderate or severe thalassemia.

During a transfusion, healthy red blood cells are given through an intravenous line. The transfused red blood cells provide haemoglobin and help improve oxygen delivery to the body’s tissues.

For severe beta thalassemia, transfusions may be required every few weeks. The exact schedule is individualised according to the patient’s haemoglobin levels, symptoms, age and treatment plan.

Regular transfusions can help:

  • Correct severe anaemia
  • Support normal growth in children
  • Improve energy and activity
  • Reduce complications associated with severe anaemia
  • Support normal development

However, repeated transfusions also introduce additional iron into the body.

This makes monitoring and management of iron overload an essential part of long-term thalassemia care.

Iron overload is one of the important complications associated with repeated blood transfusions.

Each unit of transfused red blood cells contains iron. The body has limited ability to remove excess iron, so repeated transfusions can cause iron to accumulate over time.

Excess iron can affect organs including:

  • Heart
  • Liver
  • Endocrine glands
  • Other tissues

If iron overload is not recognised and treated, it can cause serious long-term complications.

For this reason, thalassemia care is not simply about maintaining haemoglobin. It also involves monitoring and managing iron levels.

Iron chelation therapy is used to remove excess iron from the body.

Chelation medicines bind to excess iron so that it can be removed from the body.

Common chelation medicines include:

  • Deferasirox
  • Deferiprone
  • Deferoxamine

The choice of chelation therapy depends on factors such as age, iron burden, organ health, treatment tolerance and the patient’s overall medical condition.

Chelation therapy requires regular monitoring because the medicines have their own potential side effects and safety considerations.

Patients receiving regular transfusions require ongoing assessment of iron status.

Monitoring may include:

  • Serum ferritin
  • Liver function tests
  • Kidney function
  • Cardiac evaluation
  • Liver iron assessment when appropriate
  • Other investigations based on the patient’s treatment plan

The aim is to identify iron accumulation early and reduce the risk of long-term organ damage.

Regular monitoring is an important component of comprehensive thalassemia care, particularly for patients receiving long-term transfusions.

Iron overload can affect the heart in people who receive repeated transfusions.

Long-term thalassemia care may therefore include cardiac assessment when clinically appropriate.

Depending on the patient’s age, transfusion history and iron burden, the treating team may recommend:

  • Heart function assessment
  • Electrocardiogram
  • Echocardiography
  • Cardiac iron assessment when indicated
  • Other specialist investigations

The purpose is to identify complications early and adjust treatment when needed.

The liver is another organ that can be affected by iron overload.

Patients with significant transfusion exposure may require regular monitoring of:

  • Liver function
  • Iron levels
  • Liver iron concentration when indicated
  • Viral infections associated with transfusion exposure

Chelation therapy and appropriate monitoring help reduce the risk associated with excess iron.

Thalassemia can also affect bone health, particularly in people with severe disease.

Possible concerns include:

  • Reduced bone density
  • Bone pain
  • Fracture risk
  • Changes in bone development

The treating team may assess nutritional status, vitamin levels and bone health based on the patient’s age and clinical condition.

Maintaining appropriate nutrition and physical activity can also form part of long-term supportive care.

Children with severe thalassemia require monitoring not only of haemoglobin but also of their growth and development.

Regular assessment may include:

  • Height
  • Weight
  • Pubertal development
  • Nutritional status
  • Bone health
  • Endocrine function
  • School and physical activity

Good transfusion management and appropriate treatment of iron overload can help reduce complications that may interfere with normal growth and development.

Bone Marrow & Stem Cell Transplant

A potential cure for selected patients

A bone marrow transplant for thalassemia — more accurately a hematopoietic stem cell transplant — replaces the patient’s abnormal blood-forming stem cells with healthy stem cells from a suitable donor. For selected patients with severe thalassemia, this can potentially provide a cure.

Transplantation is intensive and not suitable for everyone. Donor availability, disease status, age, organ health and transplant-related risks must all be considered — which is why a specialist transplant evaluation is necessary before deciding whether it’s appropriate.

  • Detailed pre-transplant assessment
  • Donor identification & HLA compatibility testing
  • Conditioning treatment & stem cell infusion
  • Engraftment, close monitoring & supportive care

Who May Be Considered?

Type & severity of thalassemia, age, overall health, transfusion history, iron burden, heart & liver function, donor availability, HLA compatibility, and prior complications.

HLA Matching

A matched sibling can be an important donor option, but not every patient has one — other donor options may be considered depending on the transplant centre.

When to Seek Care

When should you see a specialist?

── Care Across Every Stage

Long-term care, tailored by life stage

Children

Can It Be Cured?

Transplant can potentially cure selected patients; otherwise thalassemia remains a lifelong managed condition.

Adults

Adult Thalassemia Care

Continued transfusions, iron chelation, heart & liver monitoring, bone health, endocrine assessment, and fertility & pregnancy planning.

Pregnancy

Thalassemia During Pregnancy

Monitoring haemoglobin and iron status, reviewing chelation medicines, and coordinating between hematology and obstetric teams.

Frequently asked questions

Common Questions About Thalassemia​

Thalassemia is an inherited blood disorder in which the body does not produce enough healthy haemoglobin. It can cause anaemia and ranges from mild carrier states to severe forms requiring regular medical treatment.

The two major categories are alpha thalassemia and beta thalassemia. The condition can also be described by severity, such as trait, minor, intermedia or major.

Symptoms depend on severity but can include tiredness, weakness, pale skin, shortness of breath, dizziness, headaches and fast heartbeat. Severe forms may also affect growth and cause other complications.

People with severe thalassemia generally require long-term specialist care. Treatment may include regular blood transfusions, iron chelation and monitoring for complications. People with thalassemia trait may require little or no treatment.

The frequency depends on the type and severity of thalassemia. People with severe beta thalassemia may require transfusions every few weeks, while patients with less severe forms may need them less frequently or only in particular situations.

Repeated blood transfusions can cause iron to accumulate in the body. Iron chelation therapy helps remove excess iron and reduce the risk of damage to organs such as the heart and liver.

A blood or bone marrow transplant can potentially cure thalassemia in selected patients. However, transplantation carries significant risks and requires a suitable donor and careful assessment of the patient’s health and eligibility.

No. Many patients are managed with transfusions, chelation and regular monitoring. Transplant is considered only for selected patients after assessing disease severity, donor availability, age, organ health and transplant-related risks.

A blood or bone marrow transplant can potentially cure thalassemia in selected patients. However, transplantation carries significant risks and requires a suitable donor and careful assessment of the patient’s health and eligibility.

Thalassemia trait is usually mild and often does not require specific treatment. However, identifying carrier status is important for family planning because the condition can be passed to children.

Yes. Both conditions can cause small red blood cells and anaemia. Blood counts, iron studies and haemoglobin testing can help distinguish between them.

Thalassemia trait is usually mild and often does not require specific treatment. However, identifying carrier status is important for family planning because the condition can be passed to children.

Iron should not be taken simply because a person has anaemia. Iron supplementation is appropriate when iron deficiency has been confirmed or specifically recommended by a doctor.

Carrier screening and genetic testing can help identify thalassemia-related genetic changes. When both partners are carriers, genetic counselling can help explain the potential risk to future children and available prenatal testing options.

Iron should not be taken simply because a person has anaemia. Iron supplementation is appropriate when iron deficiency has been confirmed or specifically recommended by a doctor.

Thalassemia minor or trait is generally mild and may cause little or no anaemia, while thalassemia major is a severe form that can require regular blood transfusions and ongoing treatment.

The cost depends on the type and severity of thalassemia, frequency of transfusions, chelation medicines, monitoring, investigations and whether transplantation is being considered. A personalised estimate requires review of the patient’s treatment needs.

Yes. A second opinion can help review the diagnosis, transfusion requirements, iron status, chelation plan, transplant eligibility and long-term treatment options.

Schedule Your Consultation with Dr. Neema Bhat

Whether you need a diagnosis, second opinion, or ongoing treatment – take the first step towards better blood health today.

+91 78997 56677

Emergency Line

Take the Next Step

Book a Consultation with Dr. Neema Bhat

Dr. Neema Bhat provides specialist hematology and oncology consultation for patients seeking Thalassemia Treatment in Bangalore, including children and adults requiring evaluation and long-term management of inherited blood disorders.

If you or your child has persistent anaemia, has been diagnosed with thalassemia, requires regular blood transfusions, has developed iron overload, or has been advised to consider a bone marrow or stem cell transplant, specialist evaluation can help clarify the appropriate treatment pathway.

Dr. Neema Bhat

Hematologist and Pediatric Oncologist in Bangalore, providing specialist care for thalassemia and other inherited blood disorders.

Quick Links
Related Topics
Contact

585, 2nd Main Rd, 2nd Phase, Hosakerehalli Layout, Banashankari 3rd Stage, Banashankari, Bengaluru, Karnataka 560085

+91-789-975-6677

Scroll to Top